Until vaccines against COVID-19 become available, ‘testing, testing and more testing’ to support the detection of cases and isolation of patients is the only effective strategy against the disease.
Kunal Jain, from IMAP India’s team, summarises the pharmaceutical progress on treatments for Covid-19 and highlights from a recent virtual conference on this subject in Israel the steps being taken across the world on a possible cure to halt the spread of the virus.
Teams from IMAP India and IMAP Czech Republic recently collaborated to advise NEI Limited, a leading tier-1 automotive and industrial bearings supplier in India, on their acquisition of Slovakia-based bearings manufacturer, Kinex Bearings.
39% of the deals were cross-border. Deals were closed across 13 different sectors, with Technology and Business Services the most represented.
Read the Chairman's Letter introduction to the Coronavirus special edition of IMAP's publication, Creating Value.
